REPORT: FDA recalls another blood pressure drug for possible cancer risk

Sign up for our newsletter
BY TEAM DML / NOVEMBER 13, 2018 /

GET the DML NEWS APP (FREE) Click Here

Below is a report that DML News gives a 4 OUT OF 4 STARS trustworthiness rating. We base this rating on the following criteria:

  • Provides named sources
  • Reported by more than one notable outlet
  • Does not insert opinion or leading words
  • Includes supporting video, direct statements, or photos

Click here to read more about our rating system.

As the most reliable and balanced news aggregation service on the internet, DML News offers the following information published by USATODAY.COM:

The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer.

Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). The substance is a probable human carcinogen, according to the International Agency for Research on Cancer.

The article goes on to state the following:

Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. The contaminated medication was not distributed before Oct. 8.

To get more information about this article, please visit USATODAY.COM. To weigh in, leave a comment below.



DML News offered you the above information as part of our ongoing effort to educate and inform people around the world. You can obtain additional information by visiting USATODAY.COM

Sign up for our newsletter

Leave a comment

Your email address will not be published. Required fields are marked *